David A Wood, John A Cairns, Jia Wang, Roxana Mehran, Robert F Storey, Helen Nguyen, Brandi Meeks, Vijay Kunadian, Jean-Francois Tanguay, Hahn-Ho Kim, Asim Cheema, Payam Dehghani, Madhu K Natarajan, Sanjit S Jolly, John Amerena, Matyas Keltai, Stefan James, Ota Hlinomaz, Kari Niemela, Khalid AlHabib, Basil S Lewis, Michel Nguyen, Jaydeep Sarma, Vladimir Dzavik, Anthony Della Siega, Shamir R Mehta
BACKGROUND: The COMPLETE (Complete vs Culprit-only Revascularization to Treat Multi-vessel Disease After Early PCI for STEMI) trial demonstrated that staged nonculprit lesion percutaneous coronary intervention (PCI) reduced major cardiovascular (CV) events in patients with ST-segment elevation myocardial infarction (STEMI) and multivessel coronary artery disease (CAD). OBJECTIVES: The purpose of this study was to determine the effect of nonculprit-lesion PCI timing on major CV outcomes and also the time course of the benefit of complete revascularization...
December 3, 2019: Journal of the American College of Cardiology